Rises on COVID-19 antibody test deal in UK

Quotient

11/05/2020 15:37

** Shares of diagnostics company  QTNT.O  rise 5.6% to $7.83
    ** Co enters agreement with Open Orphan Plc  ORPH.L  unit
hVIVO for using QTNT's COVID-19 antibody testing equipment in
the UK  urn:newsml:reuters.com:*:nGNX7l9xKt
    ** QTNT says its MosaiQ COVID-19 Antibody Microarray test
passed EU standards on May 1, 2020 based on testing that
demonstrated 100% ability to detect COVID-19 antibodies 
    ** Stock down ~17.6% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))